213 related articles for article (PubMed ID: 26476075)
1. Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription.
Zindler JD; Thomas CR; Hahn SM; Hoffmann AL; Troost EG; Lambin P
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26476075
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
[TBL] [Abstract][Full Text] [Related]
3. Improved effectiveness of stereotactic radiosurgery in large brain metastases by individualized isotoxic dose prescription: an in silico study.
Zindler JD; Schiffelers J; Lambin P; Hoffmann AL
Strahlenther Onkol; 2018 Jun; 194(6):560-569. PubMed ID: 29349605
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous integrated protection : A new concept for high-precision radiation therapy.
Brunner TB; Nestle U; Adebahr S; Gkika E; Wiehle R; Baltas D; Grosu AL
Strahlenther Onkol; 2016 Dec; 192(12):886-894. PubMed ID: 27757502
[TBL] [Abstract][Full Text] [Related]
5. Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
Finazzi T; Palacios MA; Spoelstra FOB; Haasbeek CJA; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):933-941. PubMed ID: 30928360
[TBL] [Abstract][Full Text] [Related]
6. [Hippocampus, brainstem and brain dose-volume constraints for fractionated 3-D radiotherapy and for stereotactic radiation therapy: Limits and perspectives].
Gérard M; Jumeau R; Pichon B; Biau J; Blais E; Horion J; Noël G
Cancer Radiother; 2017 Oct; 21(6-7):636-647. PubMed ID: 28893524
[TBL] [Abstract][Full Text] [Related]
7. Individualized dose prescription for hypofractionation in advanced non-small-cell lung cancer radiotherapy: an in silico trial.
Hoffmann AL; Troost EG; Huizenga H; Kaanders JH; Bussink J
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1596-602. PubMed ID: 22245206
[TBL] [Abstract][Full Text] [Related]
8. Critical dose and toxicity index of organs at risk in radiotherapy: analyzing the calculated effects of modified dose fractionation in non-small cell lung cancer.
Pedicini P; Strigari L; Benassi M; Caivano R; Fiorentino A; Nappi A; Salvatore M; Storto G
Med Dosim; 2014; 39(1):23-30. PubMed ID: 24239409
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity.
Goldsmith C; Plowman PN; Green MM; Dale RG; Price PM
Radiat Oncol; 2018 Oct; 13(1):204. PubMed ID: 30340643
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric comparison of brachyablation and stereotactic ablative body radiotherapy in the treatment of liver metastasis.
Pennington JD; Park SJ; Abgaryan N; Banerjee R; Lee PP; Loh C; Lee E; Demanes DJ; Kamrava M
Brachytherapy; 2015; 14(4):537-42. PubMed ID: 25944395
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.
Lievens Y; Nulens A; Gaber MA; Defraene G; De Wever W; Stroobants S; Van den Heuvel F;
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):306-13. PubMed ID: 20888706
[TBL] [Abstract][Full Text] [Related]
12. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G
Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043
[TBL] [Abstract][Full Text] [Related]
13. Potential for Isotoxic Re-irradiation Stereotactic Ablative Body Radiotherapy in Locally Recurrent Rectal Cancer.
Robinson M; O'Cathail S; Duffton A; Aitken K; Muirhead R
Clin Oncol (R Coll Radiol); 2022 Sep; 34(9):571-577. PubMed ID: 35504797
[TBL] [Abstract][Full Text] [Related]
14. 4π noncoplanar stereotactic body radiation therapy for head-and-neck cancer: potential to improve tumor control and late toxicity.
Rwigema JC; Nguyen D; Heron DE; Chen AM; Lee P; Wang PC; Vargo JA; Low DA; Huq MS; Tenn S; Steinberg ML; Kupelian P; Sheng K
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):401-9. PubMed ID: 25482301
[TBL] [Abstract][Full Text] [Related]
15. Predictive treatment management: incorporating a predictive tumor response model into robust prospective treatment planning for non-small cell lung cancer.
Zhang P; Yorke E; Hu YC; Mageras G; Rimner A; Deasy JO
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):446-52. PubMed ID: 24315562
[TBL] [Abstract][Full Text] [Related]
16. 4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors.
Dong P; Lee P; Ruan D; Long T; Romeijn E; Low DA; Kupelian P; Abraham J; Yang Y; Sheng K
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):407-13. PubMed ID: 23523322
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution's comprehensive experience.
Thibault I; Poon I; Yeung L; Erler D; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):713-9. PubMed ID: 25085765
[TBL] [Abstract][Full Text] [Related]
18. Study of 201 non-small cell lung cancer patients given stereotactic ablative radiation therapy shows local control dependence on dose calculation algorithm.
Latifi K; Oliver J; Baker R; Dilling TJ; Stevens CW; Kim J; Yue B; Demarco M; Zhang GG; Moros EG; Feygelman V
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1108-13. PubMed ID: 24529716
[TBL] [Abstract][Full Text] [Related]
19. Isotoxic radiosurgery planning for brain metastases.
Bohoudi O; Bruynzeel AM; Lagerwaard FJ; Cuijpers JP; Slotman BJ; Palacios MA
Radiother Oncol; 2016 Aug; 120(2):253-7. PubMed ID: 27212141
[TBL] [Abstract][Full Text] [Related]
20. A novel dose-volume metric for optimizing therapeutic ratio through fractionation: retrospective analysis of lung cancer treatments.
Keller H; Hope A; Meier G; Davison M
Med Phys; 2013 Aug; 40(8):084101. PubMed ID: 23927363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
